Literature DB >> 30807528

Predictive Factors of Duration of Continuous Renal Replacement Therapy in Acute Kidney Injury Survivors.

Seung Don Baek1, Jae-Young Kang2, Seulgi Shin3, Hyang-Sook Park3, Mi-Soon Kim3, So Mi Kim4, Eun Kyoung Lee4, Jai Won Chang5.   

Abstract

The factors influencing continuous renal replacement therapy (CRRT) duration for critically ill patients with acute kidney injury (AKI) are unclear. Therefore, we investigated the clinical factors that could influence the duration of CRRT for AKI survivors. In this retrospective observational study, the medical records of all hospital survivors who required CRRT for AKI in intensive care units were analyzed. The CRRT duration (median, 6 days) was categorized as short-duration CRRT (≤ 6 days, n = 65) and long-duration CRRT (> 6 days, n = 59), according to the median CRRT duration. A urine output of less than 0.5 mL/kg/h (adjusted odds ratio [OR], 3.4; P = 0.010), mechanical ventilation use (adjusted OR, 7.9; P = 0.001), and extracorporeal membrane oxygenation (ECMO) use (adjusted OR, 6.5; P = 0.010) were independent predictors of long-duration CRRT, whereas serum creatinine and neutrophil gelatinase-associated lipocalin were not significant predictors. A clinical model demonstrated a good discriminatory ability to predict long-duration CRRT (area under the curve, 0.84; 95% confidence interval, 0.76-0.90). The urine output immediately before CRRT initiation and factors associated with disease severity significantly affected the duration of CRRT. Simultaneously considering the urine output, mechanical ventilation use, and ECMO use predicted CRRT duration in AKI survivors.

Entities:  

Year:  2019        PMID: 30807528     DOI: 10.1097/SHK.0000000000001328

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  2 in total

1.  What's New in Shock, December 2019?

Authors:  Russell B Hawkins; Philip A Efron; Shawn D Larson
Journal:  Shock       Date:  2019-12       Impact factor: 3.454

Review 2.  Continuous renal replacement therapy in patients treated with extracorporeal membrane oxygenation.

Authors:  David T Selewski; Keith M Wille
Journal:  Semin Dial       Date:  2021-03-25       Impact factor: 2.886

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.